Regen BioPharma, Inc.
RGBP
$0.055
$0.000.00%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -264.90K | -130.10K | -122.50K | -349.80K | -325.00K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 16.00K | 4.30K | 4.30K | 4.40K | 900.00 |
| Total Other Non-Cash Items | 152.10K | 2.30K | 0.00 | 204.80K | 250.00K |
| Change in Net Operating Assets | -52.00K | -49.10K | -91.20K | -21.80K | 50.80K |
| Cash from Operations | -148.90K | -172.60K | -209.30K | -162.30K | -23.40K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 19.10K | -- | -- | -- | 143.80K |
| Total Debt Repaid | 40.50K | 21.00K | -25.00K | -46.50K | -- |
| Issuance of Common Stock | 28.10K | 135.30K | 187.90K | 212.30K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 87.80K | 156.30K | 162.90K | 165.80K | 143.80K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | 0.00 | 0.00 | -- |
| Net Change in Cash | -61.10K | -16.30K | -46.40K | 3.50K | 120.30K |